Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicky Perry

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
AIDS (London, England)|November 25, 2010
A phase IV, double-blind, multicentre, randomized, placebo-controlled, pilot study to assess the feasibility of switching individuals receiving efavirenz with continuing central nervous system adverse events to etravirineLaura Waters, Martin Fisher, Alan Winston, et al.
The Clinical Journal of Pain|October 21, 2014
Is HIV Painful? An Epidemiologic Study of the Prevalence and Risk Factors for Pain in HIV-infected PatientsEdwina Lawson, Caroline Sabin, Nicky Perry, et al.
Plos One|April 8, 2015
Home sampling for sexually transmitted infections and HIV in men who have sex with men: a prospective observational studyMartin Fisher, Sonali Wayal, Helen Smith, et al.
BMC Infectious Diseases|July 22, 2020
A phase IV randomised, open-label pilot study to evaluate switching from protease-inhibitor based regimen to Bictegravir/Emtricitabine/Tenofovir Alafenamide single tablet regimen in Integrase inhibitor-naïve, virologically suppressed HIV-1 infected adults harbouring drug resistance mutations (PIBIK study): study protocol for a randomised trialCollins C Iwuji, Duncan Churchill, Stephen Bremner, et al.
JMIR Research Protocols|August 10, 2022
Reducing New Chlamydia Infection Among Young Men by Promoting Correct and Consistent Condom Use: Protocol for a Randomized Controlled TrialNicole Stone, Rowena Bedford, Katie Newby, et al.
BMJ Open|July 20, 2016
Understanding HIV-positive patients' preferences for healthcare services: a protocol for a discrete choice experimentElaney Youssef, Vanessa Cooper, Alec Miners, et al.
Virology Journal|February 10, 2025
Outcomes of switching from protease inhibitor-based antiretroviral therapy to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in virologically suppressed adults with nucleos(t)ide analogue resistance- a phase IV randomised, open-label study (PIBIK study)Collins Iwuji, Laura Waters, Ana Milinkovic, et al.
AIDS and Behavior|September 3, 2016
Non-Disclosure of HIV Status and Associations with Psychological Factors, ART Non-Adherence, and Viral Load Non-Suppression Among People Living with HIV in the UKMarina Daskalopoulou, Fiona C Lampe, Lorraine Sherr, et al.
Public Health Research (Southampton, England)|October 27, 2025
Home-based intervention strategy to reduce new chlamydia infection among young men: the HIS-UK RCTNicole Stone, Cynthia Graham, Rowena Bedford, et al.
Contemporary Clinical Trials Communications|February 29, 2024
Investigating the effect of providing monetary incentives to participants on completion rates of referred co-respondents: An embedded randomized controlled trialAbby Dunn, James Alvarez, Amy Arbon, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
AIDS (London, England)|November 25, 2010
A phase IV, double-blind, multicentre, randomized, placebo-controlled, pilot study to assess the feasibility of switching individuals receiving efavirenz with continuing central nervous system adverse events to etravirineLaura Waters, Martin Fisher, Alan Winston, et al.
The Clinical Journal of Pain|October 21, 2014
Is HIV Painful? An Epidemiologic Study of the Prevalence and Risk Factors for Pain in HIV-infected PatientsEdwina Lawson, Caroline Sabin, Nicky Perry, et al.
Plos One|April 8, 2015
Home sampling for sexually transmitted infections and HIV in men who have sex with men: a prospective observational studyMartin Fisher, Sonali Wayal, Helen Smith, et al.
BMC Infectious Diseases|July 22, 2020
A phase IV randomised, open-label pilot study to evaluate switching from protease-inhibitor based regimen to Bictegravir/Emtricitabine/Tenofovir Alafenamide single tablet regimen in Integrase inhibitor-naïve, virologically suppressed HIV-1 infected adults harbouring drug resistance mutations (PIBIK study): study protocol for a randomised trialCollins C Iwuji, Duncan Churchill, Stephen Bremner, et al.
JMIR Research Protocols|August 10, 2022
Reducing New Chlamydia Infection Among Young Men by Promoting Correct and Consistent Condom Use: Protocol for a Randomized Controlled TrialNicole Stone, Rowena Bedford, Katie Newby, et al.
BMJ Open|July 20, 2016
Understanding HIV-positive patients' preferences for healthcare services: a protocol for a discrete choice experimentElaney Youssef, Vanessa Cooper, Alec Miners, et al.
Virology Journal|February 10, 2025
Outcomes of switching from protease inhibitor-based antiretroviral therapy to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in virologically suppressed adults with nucleos(t)ide analogue resistance- a phase IV randomised, open-label study (PIBIK study)Collins Iwuji, Laura Waters, Ana Milinkovic, et al.
AIDS and Behavior|September 3, 2016
Non-Disclosure of HIV Status and Associations with Psychological Factors, ART Non-Adherence, and Viral Load Non-Suppression Among People Living with HIV in the UKMarina Daskalopoulou, Fiona C Lampe, Lorraine Sherr, et al.
Public Health Research (Southampton, England)|October 27, 2025
Home-based intervention strategy to reduce new chlamydia infection among young men: the HIS-UK RCTNicole Stone, Cynthia Graham, Rowena Bedford, et al.
Contemporary Clinical Trials Communications|February 29, 2024
Investigating the effect of providing monetary incentives to participants on completion rates of referred co-respondents: An embedded randomized controlled trialAbby Dunn, James Alvarez, Amy Arbon, et al.
Pageof 3